International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 1, Supplement , Page S216, 1 September 2008

Multivariate Assessment of Tumor Angiogenesis as a Prognostic Factor for Survival in Patients with Oligodendroglioma and Anaplastic Oligodendroglioma

  • H.C. Quon

      Affiliations

    • Cross Cancer Institute, Edmonton, AB, Canada
  • ,
  • A. Hasbini

      Affiliations

    • Institut Gustave Roussy, Villejuif, France
  • ,
  • J. Cougnard

      Affiliations

    • Schering-Plough, Levallois-Perret Cedex, France
  • ,
  • L. Djafari

      Affiliations

    • Schering-Plough, Levallois-Perret Cedex, France
  • ,
  • C. Lacroix

      Affiliations

    • Hôpital Kremlin Bicetre, Le Kremlin-Bicetre, France
  • ,
  • B. Abdulkarim

      Affiliations

    • Cross Cancer Institute, Edmonton, AB, Canada

2104

Article Outline

 

Back to Article Outline

Purpose/Objective(s) 

According to World Health Organization (WHO) and Daumas-Duport grading systems, progression of oligodendrogliomas (ODGs) to a higher grade (Group III, Grade B) is associated with increased angiogenesis. Based on multivariate assessment of molecular, pathological, and radiological parameters, we further assessed the influence of tumor angiogenesis on tumor progression and patient survival.

Back to Article Outline

Materials/Methods 

Patients with a diagnosis of ODG, consecutively treated in a single institution, were reviewed and reclassified according to WHO and Daumas-Duport grading systems. The MRI scans were reviewed to assess contrast enhancement and necrosis. Tissue sections were used for pathology review and to evaluate immunostaining of VEGF, VEGF-R, Ki-67, and CD34. Multivariate analysis was performed including demographic, pathological, and radiological data associated with tumor angiogenesis and patient survival.

Back to Article Outline

Results 

A total of 134 patients were analyzed from 1994-2000. This included patients with low-grade (WHO II, n = 47) and anaplastic ODG (WHO III, n = 87). Multivariate analysis identified four independent poor prognostic factors: necrosis (p = 0.001), absence of seizure (p < 0.001), vascularization (p = 0.021), and age >55 years (p = 0.002). A subset of patients with tumor necrosis, increased vascularization, and absence of seizures had a worse outcome than predicted, with a median survival of 14.2 months. The VEGF expression was significantly higher in this subgroup and correlated with tumor progression regardless of tumor grade.

Back to Article Outline

Conclusions 

Based on the presence of radiological or pathological necrosis, contrast enhancement or endothelial hyperplasia, and absence of seizures, a high-risk group of ODG can be identified with significantly worse overall survival. Also, VEGF over-expression in Grade II ODG constitutes an early marker for predicting tumor progression to a higher grade.

 Author Disclosure: H.C. Quon, None; A. Hasbini, None; J. Cougnard, None; L. Djafari, None; C. Lacroix, None; B. Abdulkarim, None.

PII: S0360-3016(08)01421-1

doi:10.1016/j.ijrobp.2008.06.669

International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 1, Supplement , Page S216, 1 September 2008